Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular oncogenes and human carcinogenesis.

C J Der

    Clinical Chemistry
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Over 30 cellular genes are identified as potential oncogenes, crucial for cancer development. Genetic alterations in these oncogenes and suppressor genes significantly contribute to tumor progression and human oncogenesis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease.

    Oncogene·2013
    Same author

    Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling.

    Oncogene·2009
    Same author

    Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility.

    Cancer metastasis reviews·2009
    Same author

    p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.

    Oncogene·2009
    Same author

    Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

    Oncogene·2007
    Same author

    Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways.

    Molecular medicine (Cambridge, Mass.)·2002
    Same journal

    Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

    Clinical chemistry·2026
    Same journal

    Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

    Clinical chemistry·2026
    Same journal

    TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

    Clinical chemistry·2026
    Same journal

    Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

    Clinical chemistry·2026
    Same journal

    Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

    Clinical chemistry·2026
    Same journal

    In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

    Clinical chemistry·2026
    See all related articles

    Area of Science:

    • Molecular Biology
    • Genetics
    • Oncology

    Background:

    • Over the past decade, experimental studies have identified approximately 30 cellular genes as potential oncogenes.
    • These genes play a critical role in the development of various cancers.

    Purpose of the Study:

    • To summarize the current understanding of cellular oncogenes and their role in human oncogenesis.
    • To highlight the genetic events leading to oncogene activation and the potential contribution of suppressor genes to tumor progression.

    Main Methods:

    • Review of experimental studies over the past decade.
    • Analysis of genetic events leading to oncogene activation.
    • Investigation of the role of suppressor genes in tumor progression.

    Related Experiment Videos

    Main Results:

    • Identification of around 30 cellular genes as potential oncogenes.
    • Demonstration that genetic events can lead to excessive or inappropriate gene expression or aberrant gene products.
    • Evidence implicating these genes in the malignant process, although direct proof in human oncogenesis is pending.
    • Recognition that inactivation of suppressor genes may also contribute to tumor progression.

    Conclusions:

    • Cellular oncogenes and suppressor genes are critically involved in the development and progression of cancer.
    • Further research is needed to definitively prove the role of these genes in human oncogenesis.